Phase II Study of Trifluridine/tipiracil (TAS-102) Plus Irinotecan in Combination with Bevacizumab As a Second‐line Therapy for Patients with Metastatic Colorectal Cancer.
Journal of Clinical Oncology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要